The Nature of Our Business
Astrim operates as a true partnership with strong meritocracy. While our structure is corporate, our attitude is partnership. We look to invest in businesses that demonstrate high growth potential andpartner with experienced entrepreneurs and/or or management teams that possessspecialist skills and deep sector experience.
The strategic focus of each portfolio company is integrated into the group and Astrim provides support, in the form of capital resources, intellectual property and access to new business opportunities to help drive the growth strategy of each business.Ultimately, however, each management team is responsible for the day to day management of their respective businesses and for executing on the strategy. Astrim always ensures that there is a strong alignment of interests between shareholders and the various management teams. Through facilitated collaboration within the group, which involves the sharing of resources and knowledge, Astrim helps to create value by unlocking synergies and generating economies of scale. In addition to the strategic guidance provided by Astrim, there are additional value ads that the group provides in the form of balance sheet efficiencies, rationalisation benefits, treasury management, information technology and marketing services.
Currently, our business interests are split into the following operating divisions:
We focus on businesses who own Consumer Brands and registered product dossiers, and specialise in developing superior Consumer Brand products, for targeted consumer market segments. Our current products include (inter-alia): Techniblock (a sun care range) and Prodol (a teething solution for children).
We are in the process of expanding our CAMS offering by developing various new products which will soon be launched in the market
The Contract Manufacture division consists of independent third party contract manufacturers who specialise in specific areas of manufacturing expertise and, together with their intimate customer relationships are able to deliver value for money, quality products and services, on time.
We have made one investment to date, being Technikon Laboratories, an independent, licensed pharmaceutical and contract manufacturer, packer and distributor operating in Southern Africa with an established history and track record of more than 60 years. We are actively seeking to acquire other well established contract manufacturers operating in the pharmaceutical and personal care sector.
The Supply Chain division consists of enterprises specialising in key strategic supply chain partnerships, for both Group companies (specifically Brands & Contract Manufacture) as well as third party customers. Supply Chain’s principal focus is the procurement and supply of materials (pharmaceutical raw materials and packaging) by securing material supply agencies for Africa and to act as the raw material distributor for the African market. Furthermore, Supply Chain fulfils the role of Procurement Agent for our Contract Manufacturing business, by consolidating orders, negotiating better prices and delivering timely EBQ quantities.
Our Supply Chain is managed by Cocurement, a business which is controlled by Astrim. The management team of Cocurement have over 14 years of experience in the CAMS industry and an in-depth knowledge of new product development, raw material imports, quality control and the manufacturing of hard gelatine capsules. Cocurement has secured an agency agreement with Capsugel providing contractual rights for the exclusive distribution of hard capsules in South Africa. Capsugel is the world’s leading provider of empty, two-piece hard capsules and an innovator of drug delivery systems producing more than 200 billion hard capsules annually for more than 4,000 customers in over 100 countries. From assisting customers with formulation challenges to helping them bring innovative new products to market faster, Capsugel provide a unique combination of scientific, technological and global market expertise, delivering high-quality capsules and services at every step of the dosage form development process.